Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-04-08

Clinical Trial Update: Efficacy of HellenCare in Early-Stage Alzheimer's Disease [NA]

View source ↗

Summary

An update on the HellenCare trial reports efficacy signals in early-stage Alzheimer's disease. The study status is NOT_YET_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HellenCare

Snippet

Sponsor: Peking University First Hospital | Conditions: Alzheimer's Disease Dementia | NA | Status: NOT_YET_RECRUITING